Topic · page 41 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,601–1,640 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Lancet RheumatolMay 2023
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study
Cohort study
Lupus29 Apr 2023
Depression and anxiety in systemic lupus erythematosus: A case-control study on prevalence and associated factors in a single-center cohort
Cross-sectional study
Clin Exp Rheumatol28 Apr 2023
Physical exercise is associated with less fatigue, less pain and better sleep in patients with systemic lupus erythematosus
Cross-sectional study
Lupus27 Apr 2023
APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus
Cohort study
Arthritis Care Res (Hoboken)27 Apr 2023
Role of Platelet‐Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus
Diagnostic or prognostic study
Clin Exp Rheumatol26 Apr 2023
Ferroptosis in peripheral blood mononuclear cells of systemic lupus erythematosus
Mechanistic study
Lupus25 Apr 2023
Does higher quality of care in systemic lupus erythematosus translate to better patient outcomes?
Cohort study
RMD Open25 Apr 2023
Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis
Cohort study
Lupus Sci Med25 Apr 2023
Gender differences in SLE: report from a cohort of 417 Caucasian patients
Cohort study
Rheumatology (Oxford)24 Apr 2023
Which extra-renal flare is ‘difficult to treat’ in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches
Cohort study
Rheumatology (Oxford)22 Apr 2023
Paranasal sinus occupancy assessed from magnetic resonance images—associations with clinical indicators in patients with systemic lupus erythematosus
Cross-sectional study
Rheumatology (Oxford)22 Apr 2023
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus
Cohort study
Ann Rheum Dis21 Apr 2023
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes
Cohort study
Rheumatology (Oxford)20 Apr 2023
Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study
Cohort study
Lupus17 Apr 2023
Significance of the weighted complement domain of the EULAR/ACR classification criteria in juvenile onset systemic lupus erythematosus
Cohort study
Arthritis Res Ther17 Apr 2023
Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
Cross-sectional study
Lupus13 Apr 2023
Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus
Cohort study
Arthritis Care Res (Hoboken)12 Apr 2023
Sex and Racial Differences in Systemic Lupus Erythematosus Among US Adults in the All of Us Research Program
Cross-sectional study
Rheumatology (Oxford)11 Apr 2023
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist’s judgement?
Cross-sectional study
Lupus10 Apr 2023
In-person versus virtual administration of the American College of Rheumatology gold standard cognitive battery in systemic lupus erythematosus: Are they interchangeable?
Cohort study
Rheumatology (Oxford)5 Apr 2023
Clusters based on demography, disease phenotype, and autoantibody status predicts mortality in lupus: data from Indian lupus cohort (INSPIRE)
Cohort study
Lupus Sci Med5 Apr 2023
Infection-related hospitalisation in young adults with systemic lupus erythematosus: data from the National Inpatient Sample
Cross-sectional study
Lupus Sci Med3 Apr 2023
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE
Secondary analysis
Arthritis Rheumatol2 Apr 2023
Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies
Cohort study
J Rheumatol1 Apr 2023
Renal Histopathology Associated With Kidney Failure and Mortality in Patients With Lupus Nephritis: A Long-Term Real-World Data Study
Cohort study
RMD Open31 Mar 2023
Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study
Cohort study
Lupus29 Mar 2023
Depression in systemic lupus erythematosus: A manifestation of microcirculation dysfunction?
Cross-sectional study
Arthritis Res Ther28 Mar 2023
The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE
Cohort study
Clin Exp Rheumatol28 Mar 2023
A machine learning model for identifying systemic lupus erythematosus through laboratory information system and electronic medical record
Diagnostic or prognostic study
Lupus Sci Med24 Mar 2023
Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data
Secondary analysis
Lupus23 Mar 2023
The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab
Cohort study
Lupus23 Mar 2023
Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study
Cohort study
Rheumatology (Oxford)22 Mar 2023
Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State
Secondary analysis
Semin Arthritis Rheum22 Mar 2023
Racial disparities in pregnancy outcomes among women with rheumatic diseases: A systematic literature review
Meta-analysis
Arthritis Rheumatol22 Mar 2023
Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production
Mechanistic study
Arthritis Rheumatol22 Mar 2023
Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus
Cohort study
Lupus21 Mar 2023
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors
Cohort study
Rheumatology (Oxford)21 Mar 2023
Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes
Cross-sectional study
Lupus Sci Med20 Mar 2023
Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China
Cross-sectional study
Arthritis Care Res (Hoboken)20 Mar 2023
Risk of End‐Stage Renal Disease in Patients With Systemic Lupus Erythematosus and Diabetes Mellitus: A Danish Nationwide Cohort Study
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 1,601–1,640 of 1,848, newest first